FDA Inspection 1192758 — Neilmed Pharmaceuticals Inc

Neilmed Pharmaceuticals Inc — FEI 3002998723

The FDA completed an inspection of Neilmed Pharmaceuticals Inc on Dec 2, 2022 in Santa Rosa, CA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Dec 2, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Santa Rosa, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
184221 CFR 211.84(d)(1)Component identity verification
202721 CFR 211.192Investigations of discrepancies, failures
900121 CFR 211.22(a)Lack of quality control unit

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.